173 related articles for article (PubMed ID: 23302631)
21. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
22. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
Sala M; Coppa F; Cappucciati C; Brambilla P; d'Allio G; Caverzasi E; Barale F; De Ferrari GM
Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686
[TBL] [Abstract][Full Text] [Related]
23. Sexual Dimorphisms, Anti-Hormonal Therapy and Cardiac Arrhythmias.
Grouthier V; Moey MYY; Gandjbakhch E; Waintraub X; Funck-Brentano C; Bachelot A; Salem JE
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540539
[TBL] [Abstract][Full Text] [Related]
24. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
Shimizu W; Antzelevitch C
Circulation; 2000 Aug; 102(6):706-12. PubMed ID: 10931813
[TBL] [Abstract][Full Text] [Related]
25. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes.
Shimizu W; Antzelevitch C
Circulation; 1998 Nov; 98(21):2314-22. PubMed ID: 9826320
[TBL] [Abstract][Full Text] [Related]
26. The Impact of Testosterone on the QT Interval: A Systematic Review.
Gutierrez G; Wamboldt R; Baranchuk A
Curr Probl Cardiol; 2022 Sep; 47(9):100882. PubMed ID: 34103195
[TBL] [Abstract][Full Text] [Related]
27. Drug-induced QT prolongation and proarrhythmia: an inevitable link?
Ahmad K; Dorian P
Europace; 2007 Sep; 9 Suppl 4():iv16-22. PubMed ID: 17766320
[TBL] [Abstract][Full Text] [Related]
28. Sex differences in the mechanisms underlying long QT syndrome.
Salama G; Bett GC
Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H640-8. PubMed ID: 24973386
[TBL] [Abstract][Full Text] [Related]
29. Electrophysiologic characterization of the antipsychotic drug sertindole in a rabbit heart model of torsade de pointes: low torsadogenic potential despite QT prolongation.
Eckardt L; Breithardt G; Haverkamp W
J Pharmacol Exp Ther; 2002 Jan; 300(1):64-71. PubMed ID: 11752098
[TBL] [Abstract][Full Text] [Related]
30. [Ventricular arrhythmias. A potential risk associated with the use of non-cardiovascular drugs prolonging the QT interval].
Calderone V; Cavero I
Minerva Med; 2002 Jun; 93(3):181-97. PubMed ID: 12094149
[TBL] [Abstract][Full Text] [Related]
31. Computational approaches to understand the adverse drug effect on potassium, sodium and calcium channels for predicting TdP cardiac arrhythmias.
Sharifi M
J Mol Graph Model; 2017 Sep; 76():152-160. PubMed ID: 28756335
[TBL] [Abstract][Full Text] [Related]
32. Developmental changes of cardiac repolarization in rabbits: implications for the role of sex hormones.
Valverde ER; Biagetti MO; Bertran GR; Arini PD; Bidoggia H; Quinteiro RA
Cardiovasc Res; 2003 Mar; 57(3):625-31. PubMed ID: 12618224
[TBL] [Abstract][Full Text] [Related]
33. A Combined Approach Using Patch-Clamp Study and Computer Simulation Study for Understanding Long QT Syndrome and TdP in Women.
Furukawa T; Kurokawa J; Clancy CE
Curr Cardiol Rev; 2008 Nov; 4(4):244-50. PubMed ID: 20066131
[TBL] [Abstract][Full Text] [Related]
34. Drug-induced long QT syndrome and torsade de pointes.
Morissette P; Hreiche R; Turgeon J
Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
[TBL] [Abstract][Full Text] [Related]
35. Gender-related differences in ventricular repolarization: beyond gonadal steroids.
Arya A
J Cardiovasc Electrophysiol; 2005 May; 16(5):525-7. PubMed ID: 15877624
[No Abstract] [Full Text] [Related]
36. Development of models for predicting Torsade de Pointes cardiac arrhythmias using perceptron neural networks.
Sharifi M; Buzatu D; Harris S; Wilkes J
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):497. PubMed ID: 29297274
[TBL] [Abstract][Full Text] [Related]
37. The effects of hormones on arrhythmias in women.
Bailey MS; Curtis AB
Curr Womens Health Rep; 2002 Apr; 2(2):83-8. PubMed ID: 12116606
[TBL] [Abstract][Full Text] [Related]
38. [Genetic arrhythmias and gender].
Biernacka EK
Przegl Lek; 2014; 71(3):139-41. PubMed ID: 25154209
[TBL] [Abstract][Full Text] [Related]
39. Effect of epicardial or biventricular pacing to prolong QT interval and increase transmural dispersion of repolarization: does resynchronization therapy pose a risk for patients predisposed to long QT or torsade de pointes?
Medina-Ravell VA; Lankipalli RS; Yan GX; Antzelevitch C; Medina-Malpica NA; Medina-Malpica OA; Droogan C; Kowey PR
Circulation; 2003 Feb; 107(5):740-6. PubMed ID: 12578878
[TBL] [Abstract][Full Text] [Related]
40. Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart.
Bottino D; Penland RC; stamps A; Traebert M; Dumotier B; Georgiva A; Helmlinger G; Lett GS
Prog Biophys Mol Biol; 2006; 90(1-3):414-43. PubMed ID: 16321428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
